Abiopharma

🔍 SMITH BRIAN TRAVIS (Executive)

Company: EASTMAN CHEMICAL CO (EMN)

Report Date: 2025-08-27

Detailed Transactions and Holdings:

• Acquired 1,750 shares of Common Stock at $68.34 per share (Direct)
  Date: 2025-08-27 | Code: P | equity_swap_involved: 0 | shares_owned_after: 16,732.00 | transaction_form_type: 4
• Acquired 2,200 shares of Phantom Stock Units (Derivative)
  Date: 2025-08-28 | Code: J | equity_swap_involved: 0 | shares_owned_after: 2,208.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1

Footnotes:

• F1: Phantom Stock Units acquired under the Executive Deferred Compensation Plan, each having a value equal to one share of issuer common stock and payable only in cash and subject to certain acceleration and early withdrawal provisions, after termination of employment. Additional Remarks